跳至主要内容
临床试验/NCT02635594
NCT02635594已完成不适用

Effects of Carnipure® Tartrate on Postprandial Endothelial Function and Recovery From Physical Exertion in Healthy People - a Randomized, Double-blind, Placebo-controlled, Two-way Cross-over Study

Lonza Ltd.1 个研究点 分布在 1 个国家目标入组 36 人开始时间: 2015年12月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
Lonza Ltd.
入组人数
36
试验地点
1
主要终点
postprandial endothelial function

研究概览

简要总结

Investigation of 4 weeks supplementation with Carnipure® tartrate on endothelial function and parameters of recovery after physical exertion.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
25 Years 至 45 Years(Adult)
性别
All
接受健康志愿者
是

入选标准

  • •Healthy men and women between 25 and 45 years
  • •Body mass index (BMI) between 20 and 30 kg/m²
  • •Non-smoker
  • •Physically active 1-2 times per week

排除标准

  • •Competitive athlete or performance of high intensity training
  • •Nutrition with high portion of meat (> 3 times meat per week).
  • •Injury at the finger
  • •History or presence of significant cardiovascular disease or co-morbidities (i.e., diabetes, etc.)
  • •Known allergy to ingredients of study preparation
  • •Disturbed absorption due to changes in the gastrointestinal tract (e.g., resections, diverticula, blind-loop syndrome)
  • •Hypo/ hypertension or taking anti hypo/ hypertension medication
  • •Untreated thyroid dysfunction
  • •Atherosclerosis or other relevant musculoskeletal diseases/ injuries
  • •Anemia (women: Hb <11 g/ dl; men: 12.5 g/ dl)
  • •Eating disorder
  • •Present or recent use of drugs and dietary supplements that affect the endothelial function, re-covery or lipid status 2 months before or during the study (e.g. L-Carnitine, Arginine, omega3 FA, polyphenol rich supplements (e.g. OPC, cacao, etc) antihypertensive drugs, anti hyperlipidemic drugs, regular intake of protein-shakes etc.)
  • •Subjects not willing to abstain from intake of analgesic medication 24 hours prior to and during visit 1b and 3b.
  • •Female patients that are pregnant or nursing
  • •Night shift worker
  • •Donation of blood or similar blood loss within the previous 30 days before screening;
  • •Participation in a clinical trial with an investigational product within 30 days before screening
  • •Known alcohol abuse or drug abuse
  • •Known infection of human immunodeficiency virus (HIV) or hepatitis B or C
  • •Known lactose intolerance, dairy protein allergy or allergy to nuts

研究组 & 干预措施

Placebo

Placebo Comparator

1000mg cellulose + 475mg L-tartaric acid

干预措施: Placebo (Other)

Carnipure® tartrate

Experimental

1000mg of L-Carnitine provided as 1475mg Carnipure® tartrate

干预措施: L-Carnitine (Dietary Supplement)

结局指标

主要结局

postprandial endothelial function

时间窗: after 4 weeks supplementation

postprandial endothelial function assessed after 4 weeks supplementation with verum in comparison to placebo

次要结局

  • Creatin Kinase (CK) before and after exhaustive exercise(immediately before, 0h, 2h, 24h, 48h,)
  • Myoglobine (Mb) before and after exhaustive exercise(immediately before, 0h, 2h, 24h, 48h,)
  • Biomarker for vascular health(after 4 weeks supplementation)
  • Maximal strength (Nm) before and after exhaustive exercise(immediately before, 0h, 2h, 24h, 48h,)
  • pain before and after exhaustive exercise (VAS)(immediately before, 0h, 2h, 24h, 48h,)

研究者

发起方
Lonza Ltd.
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验